Worm.com

Guide to Spyware and AntiVirus Information

You are currently browsing the Worm.com weblog archives for the day Monday, April 16th, 2007.

 

April 2007
M T W T F S S
« Mar   May »
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Sponsors

Archive for April 16th, 2007

To: BUSINESS EDITORS

Contact: CWI, +1-702-456-4460, clearwae@cox.net

HENDERSON, Nev., April 16 /PRNewswire/ — CWI focuses on
delivering environmental-friendly systems that benefit humanity by
reducing deaths, sickness, and healthcare costs, while stimulating
economic growth. "Our environment is our livelihood, water and food
supply. That’s what this system is about." The New R2000 should be in
production by January 2008 or sooner. The company has moved to
Henderson, Nevada and is presently looking for offices and
manufacturing space, says Larry V. Presley, the Company’s CEO. CWI’s …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

LEIPZIG, Germany (ENS) —
–>

Outbreaks of Ebola virus over the past 12 years have killed roughly 25 percent of the world gorilla population, and now the scientists who documented these deaths say vaccination of wild gorillas could help protect those that remain.

A study published in the May issue of the journal “The American Naturalist” provides hope that newly developed vaccines can control the devastating impact of Ebola on wild apes.

The hopeful clues come from the discovery that outbreaks may be amplified by Ebola transmission between ape social groups.

“It means that vaccinating one gorilla does not protect only that gorilla, it also protects gorillas further down the transmission chain,” said Peter Walsh of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, the lead author on the study.

“Thus, protecting remaining ape populations may not require vaccinating a high proportion of individuals, as many people naively assume,” …


Read the full article with a Free Trial at MyWire.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

Hurwitz & Associates Partner and Founder of Bloor Research Discusses Why Anti-Virus Is No Longer Effective for Preventing Malware and How a Whitelisting Approach Can Protect an Organization From Malware Infection

HERNDON, Va. — SecureWave, a worldwide leader in endpoint security, today announced the availability of a podcast titled, "The Extraordinary Failure of Anti-Virus Technology: Whitelisting Succeeds Where AV Has Failed." The podcast features Robin Bloor, partner with Hurwitz & Associates and founder of Bloor Research. Bloor is at the forefront of the "Anti-Virus is Dead" (AVID) campaign, proclaiming that anti-virus technologies are ineffective and the wrong approach to malware prevention. In the podcast, Bloor discusses the genesis of AV’s failure and how a whitelisting approach can successfully protect an organization from malware infection. The podcast is available online at: http://www.securewave.com/bloorpodcast.

"The anti-virus techniques really don’t work very well. A study carried out by the Australian CERT Organization discovered that with the common anti-virus products, 80 percent of new viruses simply don’t get recognized, so they get in," said Bloor. "If you look at the surveys done by CSI/FBI each year, you discover despite the fact that more than 99 percent of companies have anti-virus technology deployed, the reality is about 60 percent of companies suffer infection every year. The AV technology is just not working. The whitelisting approach is, as far as I can see, the right way to approach malware and the right way to approach a whole other set of issues in the security space."

Bloor’s AVID campaign began when he was introduced to SecureWave’s Sanctuary, the industry’s first endpoint security solution that uses a whitelist approach to proactively protect organizations against introduction of malware and other threats. Sanctuary allows only authorized applications to execute, eliminating known and unknown threats while enabling organizations to enforce acceptable application use policies. To supplement the podcast, Bloor also authored a whitepaper entitled "The Extraordinary Failure of Anti-Virus Technology" that is available online at: http://www.securewave.com/white_papers.jsp.

"Some of today’s malicious code is sophisticated, extremely pervasive and highly customized to target specific organizations and vulnerabilities. Trying to maintain blacklists of all threats is a Herculean task that is simply no longer effective for preventing malware outbreaks," said Dennis Szerszen, senior vice president of SecureWave. "This podcast and Robin Bloor’s AVID campaign expose the holes in relying solely on anti-virus technology and reiterate what our customers already know - whitelisting is a more complete, more effective approach to preventing viruses, spyware, Trojans and other malicious code from infecting a corporate network. With whitelisting, there is no concept of the zero-day threat."

About SecureWave

With SecureWave’s Sanctuary[R], organizations set and enforce policies for device and application use that overcome tomorrow’s security and operational challenges today. More than 1,500 enterprises worldwide in the financial, government, military, manufacturing and healthcare sectors, including Lockheed Martin, CSC/Anglian Water Services, MTU, Barclays Bank PLC and Norwich Union, utilize Sanctuary. SecureWave, named a Red Herring Top 100 Innovator, is headquartered in Luxembourg and services its global customer base via offices in the U.K. and Herndon, VA, as well as through a network of reseller and service provider partners worldwide. To learn more about SecureWave, please call (703) 713-3960 or visit www.securewave.com.

COPYRIGHT 2007 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis